BG
Bhavesh Gunvantrai Acharya
About Bhavesh Gunvantrai Acharya
Data last updated:
Bhavesh Gunvantrai Acharya is an Additional Director at Oryxion Solutions Private Limited (since 2025) and Designated Partner at Leo Clinical Research Llp (since 2023). The companies operate in Pharma, Information Technology and Life Sciences. The largest current company by reported revenue is Oryxion Solutions Private Limited at ₹2.73 Cr (FY 2025). Earlier, Bhavesh Gunvantrai Acharya was a Director at Premier Research Group (India) Private Limited (2021–2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Oryxion Solutions Private Limited U63122KA2023PTC172096 | Additional Director | 01 Oct 2025 | 2023 | ₹2.73 Cr (FY 2025) | Active |
| Leo Clinical Research Llp ACC-5884 | Designated Partner | 22 Aug 2023 | 2023 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Premier Research Group (India) Private Limited U73100KA2021FTC143738 | Director | 22 May 2021 | 2021 | ₹54.70 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Bhavesh Gunvantrai Acharya
| Name | DIN | Company | Designation |
|---|---|---|---|
| Muvva Sai Ram | 10108061 | Oryxion Solutions Private Limited | Director |
| Soma Sekhar Koramatla | 10108060 | Oryxion Solutions Private Limited | Director |
| Shruti Bhavesh Acharya | 10288085 | Leo Clinical Research Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Bhavesh Gunvantrai Acharya
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bhavesh Gunvantrai Acharya
Bhavesh Gunvantrai Acharya currently holds 2 directorships: Oryxion Solutions Private Limited (Additional Director, since 01 Oct 2025, revenue ₹2.73 Cr (FY 2025)); Leo Clinical Research Llp (Designated Partner, since 22 Aug 2023).
Bhavesh Gunvantrai Acharya was first appointed on 22 May 2021 as Director at Premier Research Group (India) Private Limited. The most recent appointment on record is 01 Oct 2025 at Oryxion Solutions Private Limited.
Bhavesh Gunvantrai Acharya held 1 earlier board appointment: Premier Research Group (India) Private Limited (Director, 22 May 2021 to 23 Aug 2023).
The current boards of Bhavesh Gunvantrai Acharya's companies include Muvva Sai Ram (Oryxion Solutions Private Limited), Soma Sekhar Koramatla (Oryxion Solutions Private Limited), Shruti Bhavesh Acharya (Leo Clinical Research Llp).